Anti-Endothelial Protein C Receptor Antibody, clone 1560 clone 1560, from rat

Endothelial protein C receptor (UniProt: Q64695; also known as EPCR, Activated protein C receptor, APC receptor, Centrocyclin, Centrosomal protein CCD41, Endothelial cell protein C receptor, CD201) is encoded by the Procr (also known as Epcr) gene (Gene ID: 19124) in murine species. EPCR is a multi-functional single-pass type I membrane protein that is expressed in endothelial cells. Its expression has also been reported in hematopoietic, neuronal, epithelial progenitor cells, and breast cancer stem cells. It binds to activated protein C and enhances protein C activation by the thrombin-thrombomodulin complex and thereby plays a role in the protein C pathway controlling blood coagulation. It is also shown to play a role in mediating activated protein C-induced cytoprotective effects, including antiapoptotic, anti-inflammatory, and barrier stabilization. EPCR exhibits sequence and 3-dimensional structural homology with the major histocompatibility class 1/CD1 family of proteins, particularly CD1d. It contains a tightly bound phospholipid in the antigen presenting groove and phosphatidylcholine is shown to be the major phospholipid bound to human EPCR. Removal of this lipid results in the loss of protein C binding.